| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Gibson Christopher is a Director at RECURSION PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 44 sells.
Estimated insider holdings value: $3.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 59,794 | $7.21 | $431,025.05 | -6.6% | +37.8% | -15.4% | |
| Sep 6, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 58,765 | $8.81 | $517,441.98 | -6.3% | -21.5% | -31.8% | |
| Aug 2, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 65,015 | $13.04 | $847,711.52 | -3.5% | -59.9% | -44.3% | |
| Jul 12, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 56,818 | $12.54 | $712,242.04 | -1.5% | -41.5% | -36.4% | |
| Jun 7, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 56,436 | $9.05 | $510,807.88 | -5.8% | -4.1% | -0.7% | |
| May 3, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 58,073 | $4.79 | $278,334.90 | -5.7% | +167.7% | +70.3% | |
| Apr 6, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 53,327 | $6.60 | $351,709.78 | -2.8% | +9.6% | +33.4% | |
| Mar 9, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 110,890 | $8.05 | $892,894.24 | -5.5% | +20.9% | +49.2% | |
| Mar 2, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 21,000 | $7.92 | $166,268.05 | -2.2% | +9.5% | +59.9% | |
| Feb 2, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 21,500 | $9.22 | $198,164.50 | -2.2% | -44.9% | -0.9% |